Everest Organics Ltd. | Small-cap | Healthcare
₹414.50
0.48%
| Everest Organics Stock Comparison:
Everest Organics vs Sun PharmaceuticalEverest Organics vs Divi's LaboratoriesEverest Organics vs Sun Pharma AdvancedEverest Organics vs Sequent ScientificEverest Organics vs Gujarat ThemisEverest Organics vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 538.1M
Gross Profit 167.6M 31.15%
Operating Income 29.2M 5.43%
Net Income 14.1M 2.61%
EPS (Diluted) ₹1.45

Balance Sheet Metrics

Total Assets 2.2B
Total Liabilities 1.5B
Shareholders Equity 699.5M
Debt to Equity 2.21

Cash Flow Metrics

Revenue & Profitability Trend

Everest Organics Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.6B2.0B1.8B2.0B1.8B
Cost of Goods Sold i985.4M1.5B1.5B1.7B1.3B
Gross Profit i609.4M426.2M289.3M338.2M476.3M
Gross Margin % i38.2%21.6%15.8%16.9%26.2%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-111.4M108.7M100.6M87.2M
Other Operating Expenses i373.6M6.2M2.3M4.4M4.3M
Total Operating Expenses i373.6M117.7M111.0M105.0M91.5M
Operating Income i12.6M59.4M-26.8M42.9M200.3M
Operating Margin % i0.8%3.0%-1.5%2.1%11.0%
Non-Operating Items
Interest Income i-969.0K348.0K540.0K1.1M
Interest Expense i51.9M48.4M29.4M26.2M20.1M
Other Non-Operating Income-----
Pre-tax Income i-32.4M6.1M899.0K17.4M172.7M
Income Tax i-19.5M4.7M2.7M6.0M35.6M
Effective Tax Rate % i0.0%77.2%302.7%34.2%20.6%
Net Income i-12.9M1.4M-1.8M11.4M137.2M
Net Margin % i-0.8%0.1%-0.1%0.6%7.6%
Key Metrics
EBITDA i79.1M112.5M24.5M81.5M226.6M
EPS (Basic) i₹-2.97₹0.17₹-0.23₹1.43₹17.14
EPS (Diluted) i₹-2.97₹0.17₹-0.23₹1.43₹17.14
Basic Shares Outstanding i97105268188235792173979979028001750
Diluted Shares Outstanding i97105268188235792173979979028001750

Income Statement Trend

Everest Organics Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i60.9M2.7M2.7M6.5M16.6M
Short-term Investments i11.6M5.5M5.5M--
Accounts Receivable i884.3M1.0B763.3M685.7M506.2M
Inventory i452.5M437.6M467.4M414.9M329.2M
Other Current Assets68.5M2.0K1.0K1.0K1.0K
Total Current Assets i1.5B1.5B1.3B1.2B892.5M
Non-Current Assets
Property, Plant & Equipment i483.4M65.8M65.7M17.6M16.4M
Goodwill i31.1M16.8M21.0M--
Intangible Assets i31.1M16.8M21.0M--
Long-term Investments-----
Other Non-Current Assets23.2M1.0K--2.0K-
Total Non-Current Assets i765.8M767.4M693.7M601.2M461.3M
Total Assets i2.2B2.3B2.0B1.8B1.4B
Liabilities
Current Liabilities
Accounts Payable i957.9M1.1B951.0M795.3M547.4M
Short-term Debt i386.8M434.7M399.6M277.9M170.8M
Current Portion of Long-term Debt-----
Other Current Liabilities43.9M37.3M16.7M34.0M13.6M
Total Current Liabilities i1.4B1.6B1.4B1.1B773.6M
Non-Current Liabilities
Long-term Debt i92.0M146.4M122.8M133.4M69.9M
Deferred Tax Liabilities i20.0M45.2M41.5M38.9M35.8M
Other Non-Current Liabilities-1.0K---1.0K1.0K
Total Non-Current Liabilities i146.1M207.8M180.5M186.4M114.4M
Total Liabilities i1.5B1.8B1.6B1.3B888.0M
Equity
Common Stock i97.1M80.0M80.0M80.0M80.0M
Retained Earnings i-341.1M344.9M350.7M348.5M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i699.5M458.4M462.1M468.0M465.8M
Key Metrics
Total Debt i478.7M581.1M522.4M411.3M240.8M
Working Capital i79.8M-101.2M-51.0M53.2M118.9M

Balance Sheet Composition

Everest Organics Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i-32.4M6.1M899.0K11.4M137.2M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i21.2M-103.8M-47.0M-164.9M-61.0M
Operating Cash Flow i38.1M-44.0M-13.4M-123.0M107.6M
Investing Activities
Capital Expenditures i-35.8M-130.9M-135.3M-171.5M-68.5M
Acquisitions i-----
Investment Purchases i---00
Investment Sales i-----
Investing Cash Flow i-35.8M-134.2M-157.8M-160.7M-107.3M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i270.0M--00
Free Cash Flow i-108.0M33.3M48.8M-34.2M66.8M
Net Change in Cash i272.3M-178.2M-171.2M-283.7M372.0K

Cash Flow Trend

Everest Organics Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 67.51
Price to Book 12.73
Price to Sales 2.20
PEG Ratio -0.57

Profitability Ratios

Profit Margin 3.41%
Operating Margin 6.39%
Return on Equity -1.84%
Return on Assets -0.57%

Financial Health

Current Ratio 1.06
Debt to Equity 68.44
Beta 0.14

Per Share Data

EPS (TTM) ₹6.11
Book Value per Share ₹32.42
Revenue per Share ₹187.55

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
everesto4.0B67.5112.73-1.84%3.41%68.44
Sun Pharmaceutical 3.9T38.005.4715.08%19.29%3.26
Divi's Laboratories 1.6T70.9210.9114.64%23.89%0.03
Sun Pharma Advanced 47.4B-13.85-21.83157.88%-53.22%-1.24
Sequent Scientific 44.4B155.796.302.84%1.85%62.47
Gujarat Themis 43.5B97.6217.5119.64%30.17%12.27

Financial data is updated regularly. All figures are in the company's reporting currency.